Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant.
Rosana Wing-Shan PoonLu LuCarol Ho-Yan FongTak-Chuen IpLin-Lei ChenRicky Rui-Qi ZhangCyril Chik-Yan YipVincent Chi-Chung ChengKwok-Hung ChanKwok-Yung YuenKelvin Kai-Wang ToPublished in: Diagnostics (Basel, Switzerland) (2021)
Currently available commercial antibody assays may not predict the level of neutralizing antibodies against the variants. A new generation of antibody tests specific for variants are required.